Current Oncology (Jul 2022)

Surgical Management of Craniovertebral Junction Schwannomas: A Systematic Review

  • Paolo Palmisciano,
  • Gianluca Ferini,
  • Gina Watanabe,
  • Andie Conching,
  • Christian Ogasawara,
  • Gianluca Scalia,
  • Othman Bin-Alamer,
  • Ali S. Haider,
  • Maurizio Passanisi,
  • Rosario Maugeri,
  • Samer S. Hoz,
  • Matias Baldoncini,
  • Alvaro Campero,
  • Maurizio Salvati,
  • Aaron A. Cohen-Gadol,
  • Giuseppe E. Umana

DOI
https://doi.org/10.3390/curroncol29070384
Journal volume & issue
Vol. 29, no. 7
pp. 4842 – 4855

Abstract

Read online

Background: Craniovertebral junction (CVJ) schwannomas are rare, with surgery and stereotactic radiosurgery (SRS) being effective yet challenging options. We systematically reviewed the literature on CVJ schwannomas. Methods: PubMed, Scopus, Web-of-Science, and Cochrane were searched following the PRISMA statement to include studies reporting CVJ schwannomas. Clinical features, management, and outcomes were analyzed. Results: We collected 353 patients from 101 included articles. Presenting symptoms were mostly neck pain (30.3%) and headache (26.3%), with most cranial neuropathies involving the XII (31.2%) and X (24.4%) nerves. Most tumors originated from C2 (30.9%) and XII (29.4%) nerves, being extracranial (45.1%) and intradural-extradural (44.2%). Erosion of C1–C2 vertebrae (37.1%), the hypoglossal canal (28.3%), and/or jugular foramen (20.1%) were noted. All tumors were operated, preferably with the retrosigmoid approach (36.5%), with the far-lateral approach (29.7%) or with the posterior approach and cervical laminectomy (26.9%), far-lateral approaches (14.2%), or suboccipital craniotomy with concurrent cervical laminectomy (14.2%). Complete tumor resection was obtained most frequently (61.5%). Adjuvant post-surgery stereotactic radiosurgery was delivered in 5.9% patients. Median follow-up was 27 months (range, 12–252). Symptom improvement was noted in 88.1% of cases, and cranial neuropathies showed improvement in 10.2%. Post-surgical complications occurred in 83 patients (23.5%), mostly dysphagia (7.4%), new cranial neuropathies (6.2%), and cerebrospinal fluid leak (5.9%). A total of 16 patients (4.5%) had tumor recurrence and 7 died (2%), with median overall survival of 2.7 months (range, 0.1–252). Conclusions: Microsurgical resection is safe and effective for CVJ schwannomas. Data on SRS efficacy and indications are still lacking, and its role deserves further evaluation.

Keywords